Biora’s BT-600 novel drug-device may revolutionise targeted colon therapy

cafead

Administrator
Staff member
  • cafead   Feb 22, 2024 at 12:02: PM
via Biora Therapeutics recently announced the initiation of phase 1 clinical trials of BT-600, a novel drug-device combination for ulcerative colitis (UC) patients.

article source
 

<